Real-time enrollment status for this early alzheimer's disease clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 6:45 PM UTC
| NCT Number | NCT06709014 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Early Alzheimer's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 760 participants |
| Active Locations | 81 sites in the US |
| Sponsor | Annovis Bio Inc. |
| Last Updated on CT.gov | May 18, 2026 (2 weeks ago) |
As of June 1, 2026: Clinical trial NCT06709014 is currently active_not_recruiting participants. This clinical trial study for early alzheimer's disease is not currently accepting new participants at 81 locations across the United States. The study is sponsored by Annovis Bio Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06709014 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 81 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06709014 was last updated 2 weeks ago (May 18, 2026). HelloStudys verifies this status automatically.